The sequential administration of LH-RH analogue and chemotherapy was designed to compensate for tumour heterogeneity; oestrogen deprivation may induce apoptosis on slowly proliferating cell clones that are not sensitive to chemotherapy (27), while chemotherapy may be active in cellular clones that are rapidly proliferating. Here, GNRH1 is linked to neoplasm.